H.C. Wainwright Reiterates Buy Rating on IN8bio Inc. (INAB)

June 4, 2026 6:44 AM

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $6.00 price target on IN8bio Inc. (NASDAQ: INAB).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found